Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
Main page content
988 Suicide & Crisis Lifeline Wallet Card with Image (Spanish Version)
Published: June 2022
Tarjeta de bolsillo con imagen de 988 Línea de Prevención del Suicido y Crisis This 2-sided 3.5"x2" business-sized wallet card helps publicize the 988 Suicide & Crisis Lifeline. Esta tarjeta de bolsillo de 2 caras de 3,5 "x2" ayuda a publicitar el nuevo Línea de Prevención del Suicido y Crisis. This item comes in packs of 50.988 Suicide & Crisis Lifeline Rectangle Magnet (Spanish Version)
Published: June 2022
Imán Rectangular de 988 Línea de Prevención del Suicido y Crisis This cellphone-shaped magnet (size 3.25"x6") helps publicize the new 988 Suicide & Crisis Lifeline phone number and provides access to this life-saving resource in places that are highly visible. Este imán con forma de teléfono móvil (tamaño 3,25"x6") ayuda a publicitar el nuevo 988 Línea de Prevención del Suicido y Crisis y proporciona acceso a este recurso que salva vidas en lugares muy visibles. This item comes in packs of 50.988 Suicide & Crisis Lifeline Poster (Spanish Version)
Published: June 2022
Póster de 988 Línea de Prevención del Suicido y Crisis This 18x24 inch poster helps publicize the new 988 Suicide & Crisis Lifeline and provides access to this life-saving resource. This poster is designed to be placed in schools, community centers, counseling offices, clinics, and other settings where people gather. Este póster de 18x24 pulgadas ayuda a publicitar el nuevo 988 Línea de Prevención del Suicido y Crisis y proporciona acceso a este recurso que salva vidas. Este póster está diseñado para ser colocado en escuelas, centros comunitarios, oficinas de asesoramiento, clínicas y otros lugares donde se reúnen las personas.TIP 33: Treatment for Stimulant Use Disorders
Published: October 2021
This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.TIP 63: Medications for Opioid Use Disorder - Executive Summary
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.TIP 63: Medications for Opioid Use Disorder - Full Document
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.